Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Isoallolithocholic acid

Copy Product Info
😃Good
Catalog No. T36522Cas No. 2276-93-9
Alias Alloisolithocholic Acid, AILCA, 3β-Hydroxy-5α-cholanic acid

Isoallolithocholic acid (3β-Hydroxy-5α-cholanic acid) is a bile acid metabolite and T-cell modulator with anti-inflammatory activity, associated with human immune homeostasis.

Isoallolithocholic acid

Isoallolithocholic acid

Copy Product Info
😃Good
Purity: 99.31%
Catalog No. T36522Alias Alloisolithocholic Acid, AILCA, 3β-Hydroxy-5α-cholanic acidCas No. 2276-93-9
Isoallolithocholic acid (3β-Hydroxy-5α-cholanic acid) is a bile acid metabolite and T-cell modulator with anti-inflammatory activity, associated with human immune homeostasis.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$30-In Stock
5 mg$64-In Stock
10 mg$98-In Stock
25 mg$198-In Stock
50 mg$328-In Stock
100 mg$529-In Stock
1 mL x 10 mM (in DMSO)$98-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.31%
Appearance:Solid
Color:White to Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Isoallolithocholic acid (3β-Hydroxy-5α-cholanic acid) is a bile acid metabolite and T-cell modulator with anti-inflammatory activity, associated with human immune homeostasis.
In vitro
Isoallolithocholic acid (3β-Hydroxy-5α-cholanic acid) (20 μM) reduces Th17 cell differentiation by approximately 50% without affecting RORγt expression. It does not impact Th1 or Th2 cell differentiation, and its regulatory effect on Tregs is cell-type specific. Isoallolithocholic acid-dependent enhancement of FoxP3 expression requires mitoROS.[1]
In vivo
Isoallolithocholic acid (0.03%; in the diet; 7 days; Segmented filamentous bacteria (SFB)-colonized Jax-B6 mice) was insufficient to enhance Treg percentages both at steady state and following anti-CD3 treatment alone. Significantly enhanced the Treg population in mice treated with anti-CD3 compared to the control diet in combination with 0.3% (w/w) 3-oxo-lithocholic acid (3-oxoLCA). Reduced the number of CD45.1+ T effector cells. Enhancing Treg cells in B6 mice.[1]
SynonymsAlloisolithocholic Acid, AILCA, 3β-Hydroxy-5α-cholanic acid
Chemical Properties
Molecular Weight376.57
FormulaC24H40O3
Cas No.2276-93-9
Smiles[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@@H](O)CC[C@]12C
Relative Density.1.073 g/cm3 (Predicted)
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 27.22 mg/mL (72.28 mM), Sonication is recommended.
DMF: 1 mg/mL (2.66 mM), Sonication is recommended.
DMF:PBS (pH 7.2) (1:3): 0.25 mg/mL (0.66 mM), Sonication is recommended.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Isoallolithocholic acid | purchase Isoallolithocholic acid | Isoallolithocholic acid cost | order Isoallolithocholic acid | Isoallolithocholic acid chemical structure | Isoallolithocholic acid in vivo | Isoallolithocholic acid in vitro | Isoallolithocholic acid formula | Isoallolithocholic acid molecular weight